Alefacept

• CAT Number: I042180
• CAS Number: 222535-22-0
• Purity: ≥95%

Alefacept（Cat No.:I042180）is a biologic drug used primarily to treat moderate-to-severe chronic plaque psoriasis. It is a fusion protein that targets the CD2 receptor on T-cells, a key component of the immune system. By binding to CD2, alefacept inhibits the activation and proliferation of T-cells, which are involved in the inflammatory process of psoriasis. This helps to reduce skin cell turnover and inflammation, alleviating the symptoms of psoriasis. Alefacept is administered via injection and has been studied for its effectiveness in managing the long-term symptoms of autoimmune diseases like psoriasis.